Ken Tang
Principal

Ken has over 10 years of investment and corporate finance experience in the healthcare and life sciences industries. He is passionate about investing in transformative healthcare companies that have the potential to improve human lives.

Prior to joining K2HV, Ken was a Vice President at OrbiMed Advisors, a life sciences focused investment firm, where he was involved in numerous growth capital and royalty investments in biotechnology, medical device, diagnostics, and healthcare services companies. He was a core member of the investment team across three funds which invested over $2 billion. Prior to OrbiMed, Ken worked at HSBC and Goldman Sachs where he focused on providing debt and equity solutions, including acquisition financing, for corporates and private equity firms.

Ken graduated from Columbia University with a B.S. in Electrical Engineering. He is a Chartered Financial Analyst (CFA)® charter holder.